Cannabis company Abattis Bioceuticals Corp (CSE:ATT) (OTC:ATTBF) said on Tuesday that its wholly-owned 1185277 BC Ltd subsidiary has signed a share purchase agreement for the acquisition of 100% of Pro Natura's outstanding shares from Catalyst Investment Capital Corp in exchange for the payment of EUR6.68m to Catalyst.
Why did abattis bioceuticals Corp delist from the Canadian Securities Exchange?
Abattis Bioceuticals Corp (CSE: ATT) is to delist from the Canadian Securities Exchange. The reason behind the delisting is related to the company failing to comply with the regulations of the exchange.
When did abattis bioceuticals change its name?
The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.
